ptsd, antiviral, Hepatitis C
Showing 1 - 25 of >10,000
Diabetes, Hepatitis C, Chronic, Cardiovascular Diseases Trial run by the National Institute of Diabetes and Digestive and Kidney
Recruiting
- Diabetes Mellitus
- +2 more
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Jan 27, 2023
Liver Cancer Trial in Houston (Bevacizumab, Atezolizumab, Sofosbuvir)
Not yet recruiting
- Liver Cancer
- Bevacizumab
- +5 more
-
Houston, TexasM D Anderson Cancer Center
Feb 9, 2023
Treatment of Hepatitis c by Using Direct-acting Antiviral
Not yet recruiting
- Hepatitis C
- Direct Acting Antivirals
- (no location specified)
May 9, 2022
Chronic Hepatitis c Trial in Assiut (lipid profile, fasting insulin, fibro scan)
Recruiting
- Chronic Hepatitis c
- lipid profile
- +2 more
-
Assiut, EgyptAssiut University hospital
Feb 23, 2022
Direct-acting Antiviral Drugs in Treatment of Hepatitis C in
Completed
- Inflammatory Bowel Diseases
- Hepatitis C Virus Infection
- Assess the effectiveness and safety of DAAs in patients with IBD.
- +2 more
-
Terrassa, Barcelona, SpainHospital Universitari Mutua Terrassa
Jul 8, 2022
HEPATITIS C, Virus, Human Immunodeficiency Trial in Aurora (Directly Observed Therapy, Wirelessly Observed Therapy)
Completed
- HEPATITIS C
- Virus, Human Immunodeficiency
- Directly Observed Therapy
- Wirelessly Observed Therapy
-
Aurora, ColoradoUniversity of Colorado Anschutz Medical Campus
Mar 4, 2022
Ptsd Trial in White River Junction (Glecaprevir/pibrentasvir, Placebo)
Not yet recruiting
- Ptsd
- Glecaprevir/pibrentasvir
- Placebo
-
White River Junction, VermontWhite River Junction VAMC
Dec 12, 2022
Ptsd Trial in White River Junction (Glecaprevir / Pibrentasvir Pill)
Not yet recruiting
- Ptsd
- Glecaprevir / Pibrentasvir Pill
-
White River Junction, VermontWhite River Junction VAMC
Dec 12, 2022
Hepatitis C Virus Infection Trial in Worldwide (Sofosbuvir (SOF), Ledipasvir/Sofosbuvir (LDV/SOF), Sofosbuvir/Velpatasvir
Terminated
- Hepatitis C Virus Infection
- Sofosbuvir (SOF)
- +3 more
-
Phoenix, Arizona
- +50 more
Jan 25, 2023
Direct-acting Antiviral Agents on HCV Cognitive Function, and
Recruiting
- Depression in Chronic Hepatitis C
- Depression and Cognitive Tests
-
Chandigarh, IndiaPostgraduate Institute of Medical Education and Research
Sep 26, 2021
Hepatitis C, Chronic Trial (HCV RNA (PCR), HCV Antibody test (Point of care), AST/ALT and platelets measurement)
Not yet recruiting
- Hepatitis C, Chronic
- HCV RNA (PCR)
- +2 more
- (no location specified)
Jun 29, 2021
Effect of DAAs on Behavior of HCC in HCV Patients
Completed
- Carcinoma, Hepatocellular
- Hepatitis C
-
Cairo, Egypt
- +2 more
Jul 19, 2021
Follow up of IFN Vs DAAs HCV SVR (IFDACS Study)
Recruiting
- Chronic Hepatitis C Infection
-
Beijing, Beijing, China
- +2 more
Aug 27, 2021
Chronic Hepatitis C, Hepatitis C Virus, Compensated Cirrhosis Trial (ABT-493, ABT-530, ABT-450/r/ABT-267, ABT-333)
Chronic Hepatitis Trial in Hangzhou, Shanghai (Group A, TDF, Group B:TDF then TDF and Peginterferon alfa-2a, Group C:TDF and
Recruiting
- Chronic Hepatitis
- Group A, TDF
- +2 more
-
Hangzhou, China
- +7 more
Sep 21, 2021
Chronic Hepatitis C Infection Trial (ABT-450/r/ABT-267, ABT-333, Ribavirin)
Completed
- Chronic Hepatitis C Infection
- ABT-450/r/ABT-267, ABT-333
- Ribavirin
- (no location specified)
Jul 8, 2021
Kidney Failure, Hepatitis C, Kidney Disease, Chronic Trial in Boston (Glecaprevir and Pibrentasvir)
Recruiting
- Kidney Failure
- +2 more
- Glecaprevir and Pibrentasvir
-
Boston, MassachusettsMassachusetts General Hospital
Jun 4, 2021
Chronic Hepatitis C Infection, HBV Coinfection, Hepatitis B Reactivation Trial in Hong Kong (Ledipasvir/Sofosbuvir, Sofosbuvir
Completed
- Chronic Hepatitis C Infection
- +2 more
- Ledipasvir/Sofosbuvir
- +4 more
-
Hong Kong, Hong Kong, ChinaHumanity and Health GI and Liver Centre
Aug 27, 2021
Hepatitis C, Chronic, Opioid-Related Disorders Trial in Germany
Completed
- Hepatitis C, Chronic
- Opioid-Related Disorders
-
Munich, Bavaria, Germany
- +17 more
Apr 27, 2021
Different Antiviral Regimens for Hepatitis C Virus Relapse
Unknown status
- Hepatitis C
- +2 more
- directly acting antivirals
-
Alexandria, EgyptAlexandria University.
Dec 4, 2020
HCV Reinfection in in HIV/HCV-coinfected Patients Achieving SVR
Recruiting
- Hepatitis C Virus Infection
- +2 more
-
Douliu, Taiwan
- +6 more
Feb 23, 2021
Hepatitis C, Chronic Trial in Taiwan (PEGASYS 180 µg Q1W, P1101 180 µg Q1W, 48 doses, P1101 270µg Q1W, 48 doses)
Completed
- Hepatitis C, Chronic
- PEGASYS 180 µg Q1W
- +3 more
-
Changhua, Taiwan
- +12 more
Oct 7, 2021